Literature DB >> 25862976

Molecular characterization of 7 new established cell lines from high grade serous ovarian cancer.

Caroline Kreuzinger1, Magdalena Gamperl1, Andrea Wolf1, Georg Heinze2, Angelika Geroldinger2, Diether Lambrechts3, Bram Boeckx3, Dominiek Smeets3, Reinhard Horvat4, Stefanie Aust1, Gerhard Hamilton5, Robert Zeillinger6, Dan Cacsire Castillo-Tong7.   

Abstract

Cancer cell lines are good in vitro models to study molecular mechanisms underlying chemoresistance and cancer recurrence. Recent works have demonstrated that most of the available ovarian cancer cell lines are most unlikely high grade serous (HGSOC), the major type of epithelial ovarian cancer. We aimed at establishing well characterized HGSOC cell lines, which can be used as optimal models for ovarian cancer research. We successfully established seven cell lines from HGSOC and provided the major genomic alterations and the transcriptomic landscapes of them. They exhibited different gene expression patterns in the key pathways involved in cancer resistance. Each cell line harbored a unique TP53 mutation as their corresponding tumors and expressed cytokeratins 8/18/19 and EpCAM. Two matched lines were established from the same patient, one at diagnosis and being sensitive to carboplatin and the other during chemotherapy and being resistant. Two cell lines presented respective BRCA1 and BRCA2 mutations. To conclude, we have established seven cell lines and well characterized them at genomic and transcriptomic levels. They are optimal models to investigate the molecular mechanisms underlying the progression, chemo resistance and recurrence of HGSOC.
Copyright © 2015 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  BRCA; Cell line; High grade serous ovarian cancer; Platinum; TP53

Mesh:

Substances:

Year:  2015        PMID: 25862976     DOI: 10.1016/j.canlet.2015.03.040

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

Review 1.  An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines.

Authors:  Julie Dutil; Zhihua Chen; Alvaro N Monteiro; Jamie K Teer; Steven A Eschrich
Journal:  Cancer Res       Date:  2019-03-20       Impact factor: 12.701

Review 2.  DNA methylation changes in epithelial ovarian cancer histotypes.

Authors:  Madalene A Earp; Julie M Cunningham
Journal:  Genomics       Date:  2015-09-10       Impact factor: 5.736

3.  Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary disease.

Authors:  Hubert Fleury; Laudine Communal; Euridice Carmona; Lise Portelance; Suzanna L Arcand; Kurosh Rahimi; Patricia N Tonin; Diane Provencher; Anne-Marie Mes-Masson
Journal:  Genes Cancer       Date:  2015-09

4.  Analysis of the chemotherapeutic effects of a propadiene compound on malignant ovarian cancer cells.

Authors:  Shuqing Li; Lina Yang; Jingshu Wang; Fan Liang; Bin Chang; Huafen Gu; Honglin Wang; Gong Yang; Yaping Chen
Journal:  Oncotarget       Date:  2016-08-30

5.  USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability.

Authors:  Maura Sonego; Ilenia Pellarin; Alice Costa; Gian Luca Rampioni Vinciguerra; Michela Coan; Alexandra Kraut; Sara D'Andrea; Alessandra Dall'Acqua; Dan Cacsire Castillo-Tong; Daniela Califano; Simona Losito; Riccardo Spizzo; Yohann Couté; Andrea Vecchione; Barbara Belletti; Monica Schiappacassi; Gustavo Baldassarre
Journal:  Sci Adv       Date:  2019-05-08       Impact factor: 14.136

6.  Oncolytic virus immunotherapies in ovarian cancer: moving beyond adenoviruses.

Authors:  Joseph Hoare; Nicola Campbell; Elisabete Carapuça
Journal:  Porto Biomed J       Date:  2018-06-29

Review 7.  The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers.

Authors:  Tea Lanišnik Rižner; Theresia Thalhammer; Csilla Özvegy-Laczka
Journal:  Front Pharmacol       Date:  2017-06-19       Impact factor: 5.810

8.  Loss of PFKFB4 induces cell death in mitotically arrested ovarian cancer cells.

Authors:  Charlotte Taylor; David Mannion; Fabrizio Miranda; Mohammad Karaminejadranjbar; Sandra Herrero-Gonzalez; Karin Hellner; Yiyan Zheng; Geoffrey Bartholomeusz; Robert C Bast; Ahmed Ashour Ahmed
Journal:  Oncotarget       Date:  2017-03-14

9.  Metabolism of Estrogens: Turnover Differs Between Platinum-Sensitive and -Resistant High-Grade Serous Ovarian Cancer Cells.

Authors:  Stefan Poschner; Judith Wackerlig; Dan Cacsire Castillo-Tong; Andrea Wolf; Isabel von der Decken; Tea Lanišnik Rižner; Renata Pavlič; Anastasia Meshcheryakova; Diana Mechtcheriakova; Monika Fritzer-Szekeres; Theresia Thalhammer; Walter Jäger
Journal:  Cancers (Basel)       Date:  2020-01-23       Impact factor: 6.639

10.  TIMP-1 is Overexpressed and Secreted by Platinum Resistant Epithelial Ovarian Cancer Cells.

Authors:  Maura Sonego; Evelina Poletto; Eliana Pivetta; Milena S Nicoloso; Rosanna Pellicani; Gian Luca Rampioni Vinciguerra; Francesca Citron; Roberto Sorio; Maurizio Mongiat; Gustavo Baldassarre
Journal:  Cells       Date:  2019-12-18       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.